approval · primary record
INSULIN LISPRO RECOMBINANT
FDA · BLA · 2025-05-07
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2025-05-07 |
| Brand | HUMALOG KWIKPEN |
| Sponsor | ELI LILLY AND CO |
| Route | SUBCUTANEOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:34:57.032Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:INSULIN LISPRO RECOMBINANT:2025-05-07
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.